PATH
Menu

Filter browse results

Total results with these characteristics: 50

Subject: Health technologies > Woman-initiated protection

Page 2 of 3
Meeting Family Planning Needs: PATH Provides Solutions to Expand Access to Products and Services

This fact sheet describes PATH's work to expand access to family planning products and services in low-resource settings.

Publication date: December 2011

Region: Global

Part of series: Areas of focus fact sheets

Technology Solutions to Improve Global Health: PATH Advances Appropriate, Affordable, and Lifesaving Technologies Tailored to Developing Countries

This fact sheet provides an overview of PATH's work to adapt, design, develop, and advance health technologies to improve global health.

Publication date: December 2011

Region: Global

Part of series: Areas of focus fact sheets

PATH in Kenya: Innovation and Partnership to Improve Health

This brochure outlines PATH's work to help Kenya's health care sector improve services and strengthen community networks while empowering Kenyans to adopt healthier lifestyles. PATH offers novel approaches and technical expertise to address a range of health challenges, and we manage projects that reach millions of Kenyans.

Publication date: November 2011

Region: Africa

PATH in South Africa: A Comprehensive Approach to Improving Maternal and Child Health

This brochure outlines PATH's work to improve health in South Africa by bringing effective interventions to the people who need them most. Our interventions make birth safer, enhance infant and young child health, combat HIV/AIDS, strengthen health systems, and support improved sanitation.

Publication date: October 2011

Region: Africa

Home-Based Administration of depo-subQ provera 104™ in the Uniject™ Injection System

This literature review details the key findings on the feasibility and acceptability of home delivery of depo-subQ provera 104™ in the Uniject™ injection system  (depo-subQ in Uniject). The review focused on self-injection and looked specifically at subcutaneous depot medroxyprogesterone acetate (DMPA) compared to the intramuscular formulation; considerations for home administration of injectable contraception, particularly in low-resource settings; and identified research needs for home administration, including self-injection, of depo-subQ in Uniject. A six-page briefing summary of this review is also available.

Author: Keith BM

Publication date: July 2011

Region: Global

PATH Today (Spring 2011)

Featured in this issue of PATH Today are stories and photos from the historic launch of a new meningitis vaccine in Burkina Faso. Also included are updates on projects receiving support from the Catalyst Fund, announcement of a seventh consecutive top rating from Charity Navigator, and a spotlight on Breakfast for Global Health sponsor CB Richard Ellis.

Publication date: May 2011

Region: Global

Part of series: PATH Today

Assessing Demand for depo-subQ in Uniject: A Five-Country Modeling Exercise

This brief summarizes the strategic demand models developed by PATH and the Futures Institute for the injectable contraceptive depo-subQ provera 104™ in the Uniject™ injection system (depo-subQ in Uniject) in Kenya, Malawi, Pakistan, Rwanda, and Senegal. These models will help inform global and country introduction planning for depo-subQ in Uniject.

Publication date: February 2011

Region: Global

Logistics and Waste Management Benefits of depo-subQ in Uniject

This brief describes results from an analysis conducted by PATH comparing the current intramuscular version of depot medroxyprogesterone acetate (DMPA) injectable contraceptive compared with a new formulation packaged in the Uniject injection system. The analysis focused on waste management implications, identifying key quantitative and qualitative differences between the two products.

Publication date: February 2011

Region: Global

The Uniject Injection System: Multi-country Experience and Evidence

This brief summarizes key findings from a literature review conducted by PATH to identify published and gray literature reporting international experiences with the Uniject injection system. The findings shed light on user acceptability and highlight potential cost savings in terms of training time, waste management, and reduction in drug wastage when Uniject is used instead of a standard autodisable syringe. This document synthesizes the experience and evidence on the use of Uniject worldwide with medicines such as the injectable contraceptive Cyclofem®, hepatitis B and tetanus toxoid vaccines, as well as the drug oxytocin, which is used to prevent postpartum hemorrhage.

Publication date: February 2011

Region: Global

Communications Handbook for Clinical Trials

This handbook is a practical guide developed for site-level microbicide researchers, communicators, advocates, and others working on HIV prevention trials in developing countries. It includes context-specific case studies and practical insights from actual clinical trial communications initiatives. It is being updated to include work sheets and slide sets. To apply for a complimentary copy, please email Jacqueline Borodan at jacqueline@avac.org for detailed instructions.

Author: Robinson E, Baron D, Heise L, Moffett J, Harlan SV

Publication date: May 2010

Region: Global

Saving Lives With Multipurpose Prevention Technologies: Turning Ideas Into Solutions for Sexual and Reproductive Health

This publication describes the public health potential of multipurpose prevention technologies -- that is, technologies that prevent unintended pregnancy; sexually transmitted infections, including HIV; and/or other reproductive tract infections. While a few such technologies exist, greater collaboration and resources are needed to accelerate research and development efforts and bring new technologies into widespread use.

Author: Holt BY, Kilbourne-Brook M, Cohen J, Burns M

Publication date: May 2010

Region: Global

Standards of Prevention in HIV Prevention Trials

This report covers a 2009 consultation in Kampala, Uganda, that was convened by the Global Campaign for Microbicides, the Joint UN Programme on HIV/AIDS, and the US Centers for Disease Control and Prevention. It includes recommendations related to key ethical and practical questions on the design and implementation of clinical trials.

Author: McGrory E, Philpott S, Hankins C, Paxton L, Heise L

Publication date: May 2010

Region: Global

PATH Today (Spring 2009)

This edition of PATH Today features our work in women's health and with the Entre Amigos project in Nicaragua and spotlights Margarita Quintanilla, PATH's Nicaragua country program leader. The issue also highlights PATH's breakthrough development of freeze-stable vaccines, an award for PATH vice president Dr. Michael Free, and the McKinstry Co. Charitable Foundation's commitment to health.

Publication date: May 2009

Region: Global

Part of series: PATH Today

Initial Country Assessments for depo-subQ provera 104™ in the Uniject™ Injection System

These executive summaries reveal findings and recommendations from initial assessments conducted in Bangladesh, Ethiopia, Kenya, Malawi, Nigeria, Pakistan, Rwanda, and Senegal. These countries were evaluated in terms of service delivery, supply systems, and stakeholder perspectives with respect to the feasibility and appropriateness of introducing depo-subQ in Uniject.

Publication date: 2009

Region: Global

PATH Today (Fall 2008)

This issue of PATH Today features our Sure Start project, new study results on the Ultra Rice technology, and brief updates on PATH's Woman's Condom, the Washington Global Health Alliance, and more. The issue also includes a profile on PATH donor Jay Ingram.

Publication date: September 2008

Region: Global

Part of series: PATH Today

The First 55 Steps: Report of the Microbicide Development Strategy’s Civil Society Working Group

This report provides an overview of the status of civil-society engagement in each phase of microbicide research, development, and introduction and identifies the resources and specific action steps needed to move from the current level of engagement to where we need to be. .

Author: Forbes A, Sylla L, Yassky R

Publication date: February 2008

Region: Global

Directions in Global Health (Volume 4, Issue 2)

This special issue of Directions in Global Health features PATH's work in women's health. Featured projects include Sure Start; the Maternal and Newborn Health Technology Initiative; the Prevention of Postpartum Hemorrhage Initiative; Global Campaign for Microbicides; SILCS diaphragm; the PATH Woman's Condom; microbicide applicators; AIDS, Population, and Health Integrated Assistance II Western Province; and Spring Bud Healthy Development.

Publication date: September 2007

Region: Global

Part of series: Directions in Global Health

The Female Condom: Significant Potential for STI and Pregnancy Prevention (Outlook, vol. 22, no. 2)

This issue of Outlook provides new information about the female condom as presented at the September 2005 Global Consultation on the Female Condom. Topics include evidence of the female condom's effectiveness for prevention of STIs and pregnancy, issues related to expanding access and use, and gaps in the knowledge base. Successful program examples and a detailed table of female condoms currently available or under development are also presented.

Author: Shane B

Publication date: May 2006

Region: Global

Part of series: Outlook

Female Condom: A Powerful Tool for Protection

More than 100 experts from 15 countries met in Baltimore, Maryland, in September 2005 at the Global Consultation on the Female Condom (GCFC) to discuss the status of the female condom worldwide and to develop a plan of action to build support for the method. This document answers key questions about the female condom and builds on the momentum created at the GCFC by presenting evidence of the female condom's effectiveness and impact, identifying current challenges to wider use, and indicating the steps that need to be taken now to develop strong female condom programs worldwide.

Publication date: 2006

Region: Global

SILCS Diaphragm: Design History

This document provides an historical profile on the design of PATH's SILCS diaphragm, including clinical evaluations, user acceptability studies, and product features, specifications, and benefits.

Publication date: 2006

Region: Global

Page 2 of 3